Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by periods of
remission and periods of relapse. Patients often present with symptoms such as rectal …

Abstract Treatment of patients with ulcerative colitis (UC) has traditionally focused on
improving symptoms, with the main objective of inducing and maintaining symptomatic …

Background & Aims The paradigm for treatment for ulcerative colitis (UC) is shifting from
resolving symptoms toward objective measures such as mucosal healing (MH). However, it …

Ulcerative colitis (UC), a chronic, relapsing, remitting disease of the colon and rectum, is
characterized by inflammatory ulceration of the mucosa. Current UC therapy relies on …

Introduction: Currently, mucosal healing is considered as a composite treatment end-point in
inflammatory bowel disease (IBD) since it has been demonstrated to improve disease …

Background Mucosal healing (MH) as a treatment target for ulcerative colitis is of growing
interest because it is associated with improved clinical outcomes. However, the feasibility …

Introduction Currently, treatment goals in ulcerative colitis aim to achieve clinical remission
and endoscopic mucosal healing. Emerging evidence suggests that histologic assessment …

The definition of remission in Crohn's disease and ulcerative colitis has evolved to include
mucosal healing as a measure of treatment efficacy. Randomized, controlled trials have …

In recent years mucosal healing has emerged as an important therapeutic goal for patients
with inflammatory bowel disease. Growing evidence suggests that achieving mucosal …

Over the past years, mucosal healing has emerged as a major therapeutic goal in clinical
trials in inflammatory bowel diseases. Accumulating evidence indicates that mucosal …